PPBT Purple Biotech Ltd.

NASDAQ
$1.71

Purple Biotech Ltd. (PPBT) is expected to report earnings on November 13, 2026, before the market open.

Purple Biotech Reported Earnings
Tuesday, November 17, 2026 · 7:55 AM ET
Earnings Date
4th Quarter, Dec 2026
Nov 13
Friday · 7:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Purple Biotech Ltd.

Purple Biotech Ltd. is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.